Breast Cancer Advice Center

Home > Breast Cancer Treatment Information > Breast Cancer Treatment News

Breast Cancer Treatment News

  • Breakthrough Breast Cancer In Response To The Publication Of The Cancer Reform Strategy 1 Year On Report Published By ... Tue, 02 Dec 2008 09:07:10 -0600Jeremy Hughes, Chief Executive of Breakthrough Breast Cancer says: "The Cancer Reform Strategy (CRS) has made steady progress since its publication last year. Breakthrough is particularly delighted to see our Service Pledge for Breast Cancer - a tool developed to enable health professionals and patients work together towards improved breast cancer services - is highlighted in today's report.
  • Winning hand for breast cancer Sun, 30 Nov 2008 23:11:02 -0600NORTH ADAMS -- When Bennington, Vt., artist Viola Moriarty began chemotherapy after being diagnosed with breast cancer in early 2007, she found the treatment did more than strip her of her energy and her ability to focus for long periods of time -- it also kept her away from her easel.
  • Ask the Doctor at Saint John’s: The latest Advances in Radiation Treatment of Cancer Tue, 02 Dec 2008 16:23:16 -0600Q. What are the latest advances in radiation treatment of various types of Cancer? A. By Paul Song, M.D., radiation oncologist at Saint John’s Health Center.
  • News Thu, 04 Dec 2008 17:35:57 -0600A main drug treatment for breast cancer for more than 20 years has been found to make the disease worse in some patients by boosting a chemical which makes cancer cells more active.
  • Some don't finish breast cancer treatment Tue, 02 Dec 2008 19:21:39 -0600 NEW YORK, Dec. 2 (UPI) -- One out of 5 older women may delay or not finish treatment following breast cancer surgery, U.S. researchers said.
  • Delays in radiation therapy lead to increased breast cancer recurrence Mon, 01 Dec 2008 15:29:31 -0600( New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College ) A new analysis of the National Cancer Institute's cancer registry has found that as many as one in five older women experience delayed or incomplete radiation treatment following breast-conserving surgery and that this suboptimal care can lead to worse outcomes.
  • Women with Implants See Better Results in Breast Cancer Treatment with Brachytherapy Mon, 01 Dec 2008 10:37:59 -0600●Brachytherapy can successfully treat early-stage breast cancer in women with implants and preserve the breast's appearance. ●Breast brachytherapy substantially reduces the risk of implant hardening.
  • New Mammography Technology Effective In Detecting Breast Cancer Wed, 03 Dec 2008 05:20:51 -0600A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman's hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer. Results will be presented today at the annual meeting of the Radiological Society of North America (RSNA).
  • Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer Tue, 02 Dec 2008 14:19:16 -0600Title: Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer Category: Health News Created: 12/2/2008 2:00:00 AM Last Editorial Review: 12/2/2008
  • Delay in cancer treatment is found to raise recurrence Mon, 01 Dec 2008 23:38:39 -0600Even short delays in obtaining radiation therapy worsened outcomes for older women with early-stage breast cancer, a new study suggests.
  • Bracelet sale to benefit woman with breast cancer Wed, 03 Dec 2008 08:20:31 -0600A trio of friends knew Beth Gibbons, of rural Indiana, was in for a rough spell after she was diagnosed with breast cancer this summer. At first they arranged a meal chain to ensure the Gibbons family would have home-cooked dinners.
  • BU president treated for breast cancer Wed, 03 Dec 2008 20:03:29 -0600 In a letter to the Bradley University community on Wednesday, President Joanne Glasser announced she was recently diagnosed with breast cancer.
  • (AFX UK Focus) 2008-12-04 00:16 Study sheds light on breast cancer drug failure Wed, 03 Dec 2008 18:31:24 -0600LONDON, Dec 4 (Reuters) - The most commonly used breast cancer drug may cause tumours to spread in a small number of women with low levels of a protein which makes cells stick together, British researchers said on Thursday. The findings could lead to new tests to determine which women are not likely to benefit from tamoxifen and who should be given other drugs, said Stephen Hiscox, a cancer ...
  • New Program Offers Breast Cancer Clinicians and Patients Support for Pre-Operative Clinical Assessment and Ongoing ... Tue, 02 Dec 2008 09:00:00 -0600 The Patient Advocate Foundation , with support from ImpediMed Ltd. , is pleased to announce the launch of the Lymphedema CareLine . PAF, through its MedCare Division, is offering the national, toll-free patient/provider hotline designed to provide information and assistance to breast cancer patients who are or may be at risk for post-treatment side effects such as lymphedema .
  • Researchers Use Affymetrix Technology to Discover Why Some Breast Cancer Patients Resist Tamoxifen Mon, 01 Dec 2008 07:00:00 -0600 SANTA CLARA, Calif.----Affymetrix Inc., announced today that scientists at Cancer Research UK have used Affymetrix technology to discover the molecular basis for tamoxifen response in breast cancer cells - and the reason why some women can develop resistance to the treatment.
  • Clinic offers free breast exams Thu, 04 Dec 2008 18:30:58 -0600Reddy Medical Clinic in Clinton is sponsoring free clinical breast exams from 1-4 p.m. Friday, Oct. 31, in honor of National Breast Cancer Awareness Month.
  • Researchers Use Affymetrix Technology to Discover Why Some Breast Cancer Patients Resist Tamoxifen Mon, 01 Dec 2008 07:42:23 -0600Affymetrix Inc., (Nasdaq:AFFX) announced today that scientists at Cancer Research UK have used Affymetrix technology to discover the molecular basis for tamoxifen response in breast cancer cells - and the reason why some women can develop resistance to the treatment. Their findings are published in Nature 1 .
  • Dr. Sheldon Feldman Appointed Chief of Breast Surgery at NewYork-Presbyterian Hospital/Columbia University Medical ... Thu, 04 Dec 2008 16:28:51 -0600A leading authority in minimally invasive breast cancer surgery and cancer prevention, Dr. Sheldon Feldman has been appointed chief of breast surgery at NewYork-Presbyterian Hospital/Columbia University Medical Center and assistant professor of surgery at Columbia University College of Physicians and Surgeons.
  • When Mammograms Aren't Enough: New Innovations Help Catch Breast Cancer Early Thu, 04 Dec 2008 05:55:08 -0600(ARA) - Following a false diagnosis of stomach cancer, it took five years of countless doctors, tests and hospital visits before Barbara Robertson was accurately diagnosed with breast cancer.
  • Popular breast cancer drug 'could make disease more aggressive' Thu, 04 Dec 2008 07:14:24 -0600London, Dec 4 : For some women, a leading breast cancer drug, called Tamoxifen, could make the disease more aggressive, according to scientists.
  • Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer Mon, 01 Dec 2008 13:02:20 -0600 MONDAY, Dec. 1 (HealthDay News) -- Women who have had their breasts augmented with implants and are later diagnosed with early-stage breast cancer may be treated successfully with a partial-breast radiation treatment known as brachytherapy, according to an Arizona physician and researcher.
  • HER2 may be key in treating metastatic breast cancer Thu, 04 Dec 2008 02:33:07 -0600PHILADELPHIA – Dec. 3, 2008 – Women with HER2-positive breast cancer benefit from lapatinib (TYKERB®), while women with HER2-negative breast cancer gain no incremental benefit, a new study shows.
  • New Breast Cancer Scan Cuts False Alarms Wed, 03 Dec 2008 14:17:25 -0600Title: New Breast Cancer Scan Cuts False Alarms Category: Health News Created: 12/3/2008 Last Editorial Review: 12/3/2008
  • Study sheds light on breast cancer drug failure Wed, 03 Dec 2008 18:21:00 -0600The most commonly used breast cancer drug may cause tumours to spread in a small number of women with low levels of a protein which makes cells stick together, researchers said on Thursday.
  • Timely Radiation Beneficial For Cancer Treatment Wed, 03 Dec 2008 20:00:08 -0600Researchers at Weill Cornell Medical College found that for women over the age of 64 with early breast cancer delays in post surgical radiation significantly increased the risk of the cancer coming back.
  • Chester breast cancer survivors turn charity calendar girls Thu, 04 Dec 2008 03:41:53 -0600A GROUP of women who have survived breast cancer have launched a charity calendar. The calendar is raising funds towards an ultrasound scanner for the Ursula Keyes Breast Care Unit at the Countess of Chester Hospital.
  • EIN News Introduces 'Breast Cancer News Today'; Website Offers Information on Risk Factors, Treatment, Drugs Tue, 02 Dec 2008 10:41:00 -0600 EIN News has announced the launch of a new health website providing in-depth news on breast cancer.
  • Protein That Determines Cell Polarity Prevents Breast Cancer, Study Suggests Thu, 04 Dec 2008 09:44:34 -0600A team of scientists has found that a protein called Scribble, originally discovered as a cell-shape regulator in fruit flies and worms, is an important regulator of breast cancer. They report that Scribble normally directs breast epithelial cells to form the structures that give breast tissue its shape and thereby resist cancer formation. When Scribble stops functioning, the tissue loses its ...
  • Delays In Radiation Therapy Lead To Increased Breast Cancer Recurrence, Analysis Shows Tue, 02 Dec 2008 17:29:24 -0600A new analysis of the National Cancer Institute's cancer registry has found that as many as one in five older women experience delayed or incomplete radiation treatment following breast-conserving surgery and that this suboptimal care can lead to worse outcomes.
  • Study sheds light on breast cancer drug failure Thu, 04 Dec 2008 06:26:22 -0600The most commonly used breast cancer drug may cause tumours to spread in a small number of women with low levels of a protein that makes cells stick together, British researchers said on Thursday.
  • Cancer drug stimulates infected cells Thu, 04 Dec 2008 17:34:46 -0600A main drug treatment for breast cancer for more than 20 years has been found to make the disease worse in some patients by boosting a chemical which makes cancer cells more active. Tests by Britis
  • Bradley University president has cancer Thu, 04 Dec 2008 10:17:02 -0600Bradley University President Joanna Glasser says she has breast cancer and will start treatment early next year.
  • Study sheds light on breast cancer drug failure Thu, 04 Dec 2008 09:46:15 -0600The most commonly used breast cancer drug, tamoxifen, may cause tumours to spread in a small number of women with low levels of a protein which makes cells stick together. British researchers says findings could lead to new tests to determine which women should be given other drugs.
  • PharmaMar Submits Registration Dossier To The EMEA For Yondelis(R) For Treatment Of Relapsed Ovarian Cancer Thu, 04 Dec 2008 13:10:43 -0600PharmaMar announced today the submission of a registration dossier to the European Medicines Agency (EMEA) for Yondelis® (trabectedin) when administered in combination with DOXIL®/Caelyx™ (pegylated liposomal doxorubicin) for the treatment of women with relapsed ovarian cancer (ROC).
  • Breast cancer treatment effective in women with implants Mon, 01 Dec 2008 07:21:56 -0600Washington, Dec 1 : Women with early-stage breast cancer who have had breast implants can be effectively treated with a partial-breast radiation treatment, say researchers.
  • Breast cancer drug may cause tumors to spread Thu, 04 Dec 2008 13:09:08 -0600The most commonly used breast cancer drug may cause tumors to spread in a small number of women with low levels of a protein which makes cells stick together, researchers say.
  • HER2 levels may aid in treatment selection for metastatic breast cancer Tue, 02 Dec 2008 11:50:39 -0600Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. In addition, a misclassification of metastatic breast cancer patients by as much as 10 ...
  • Breast cancer treatment offers better outcome to women with implants Sun, 30 Nov 2008 23:29:59 -0600( Radiological Society of North America ) Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented at the annual meeting of the Radiological Society of North America.
  • HER2 levels may aid in treatment selection for metastatic breast cancer Tue, 02 Dec 2008 09:42:49 -0600( American Association for Cancer Research ) Findings published in the Dec. 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. In addition, a misclassification of metastatic ...
  • Studies Evaluate Breast Cancer Outcomes In Older Patients, Women With Breast Augmentations Wed, 03 Dec 2008 07:22:07 -0600The following summarizes news coverage of two recent studies on breast cancer treatment.~ Older Patients: One in five women ages 65 and older delayed or did not complete their full radiation regimen after breast-conserving surgery, leading to an increased risk of death or recurrence, according to a study published online Monday in Cancer, the New York Times reports.
  • Breast Cancer Treatment Offers Better Outcome To Women With Implants Mon, 01 Dec 2008 09:21:11 -0600Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
  • Chemo drug aids one type of breast cancer Thu, 04 Dec 2008 12:45:23 -0600 LOS ANGELES, Dec. 4 (UPI) -- A breast cancer chemotherapy drug shows benefits to one type of breast cancer but not for another type, U.S. researchers said.
  • Bradley president says she has breast cancer Wed, 03 Dec 2008 19:16:37 -0600PEORIA, Ill. (AP) - Bradley University President Joanna Glasser says she has breast cancer and will start treatment early next year. Glasser said in a letter e-mailed to university faculty and others on Wednesday that doctors found the cancer early.
  • Drug fights one type of breast cancer Thu, 04 Dec 2008 13:15:51 -0600 LOS ANGELES, Dec. 4 (UPI) -- A breast cancer chemotherapy drug shows benefits in fighting one type of breast cancer but not another type, U.S. researchers say.
  • On the Move With a New Breast Cancer Resource Wed, 03 Dec 2008 18:54:07 -0600(ARA) - When a woman is first diagnosed with breast cancer, all kinds of questions go through her mind, and not all of them are about the cancer itself. "Will I be able to remain active? What kind of impact will treatment have on my lifestyle? Can I still be intimate with my significant other?"
  • Breast cancer treatment offers better outcome to women with implants Mon, 01 Dec 2008 11:06:30 -0600Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Patients treated with brachytherapy have better cosmetic outcomes and avoid the risk of the implant hardening, ...
  • HER2 Levels May Aid In Treatment Selection For Metastatic Breast Cancer Wed, 03 Dec 2008 11:05:48 -0600Findings published in the December 1, 2008, issue of Clinical Cancer Research , a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit.
  • Study sheds light on breast cancer drug failure Thu, 04 Dec 2008 07:58:12 -0600 The most commonly used breast cancer drug may cause tumors to spread in a small number of women with low levels of a protein which makes cells stick together, British researchers said on Thursday.
  • Breast cancer treatment offers better outcome to women with implants: Study Tue, 02 Dec 2008 06:55:51 -0600Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA). Patients treated with brachytherapy have better cosmetic outcomes and avoid the risk of the implant hardening, compared to ...
  • High Tech Breast Cancer Treatment Comes to the First Coast Wed, 03 Dec 2008 22:07:08 -0600JACKSONVILLE, FL -- As a nurse of 29 years, Carol Robinson has dealt with breast cancer on many levels, but never on her own until this September.